• For Institutions

  • Download
  • Help
  • About

longbridgelongbridge
longbridgelongbridge
Products
Pricing
Markets
Global Markets
Stock Screener
Information
Insights
News
Live
Academy
Affiliate Program
Promotions
PortAI
EN
English
简体中文
繁體中文
繁體中文(廣東話)Posts & comments will be shown in Cantonese
Search...
Quote ListQuote List
Overview
News
Financials
© 2025 Longbridge|Disclaimer

Trending

Pinned News

Novo Nordisk’s New Study on Ziltivekimab: A Potential Game-Changer in Heart Attack Treatment

Event Tracking

Dec14
Novo Nordisk Announces Ziltivekimab Heart Disease Study Plans
16:41
Coppell Advisory Solutions LLC Purchases Shares in Novo Nordisk A/S
10:00
Novo Nordisk launches its blockbuster diabetes drug Ozempic in India
09:51
2 Predictions for Novo Nordisk in 2026
09:50
Investment firm Evergreen Capital increases its stake in Novo Nordisk
00:00
Dec13
Novo Nordisk's Wegovy label update receives approval from India's CDSCO panel
22:11

Schedules & Filings

Schedules
Filings
Feb4
Earning Release(EST)

FY2025 Annual Earning Release

Nov5
Earning Release(EST)

FY2025 Q3 Earning Release (USD) Revenue 11.78 B, Net Income 3.143 B, EPS 0.707

Novo Nordisk A/S (NVO.US) Q3 2025 Earnings Conference CallNovo Nordisk A/S (NVO.US) Q3 2025 Earnings Conference Call
Aug26
Distribution Plan(EST)

Cash dividend 0.5843 USD

View More

Stock List

Top Gainers
Top Decliners
China Concepts
Symbol
Price
%Chg
Change
MSOX
7.940
+107.85%
+4.120
YCBD
1.200
+90.17%
+0.569
THH
15.520
+57.72%
+5.680
WEED
25.325
+55.65%
+9.055
NCI
1.920
+54.84%
+0.680
CNBS
34.820
+54.57%
+12.293
MSOS
5.800
+54.26%
+2.040
CGC
1.740
+53.98%
+0.610
RYM
23.800
+47.73%
+7.690
TLRY
12.150
+44.13%
+3.720
View More